Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
73 participants
INTERVENTIONAL
2013-06-30
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There is no generic hyperbaric form of levobupivacaine currently available so we aimed in this study that to find the appropriate concentration of the levobupivacaine which achieves unilateral spinal anesthesia. The potential benefits of this type of anesthesia are less motor blockade and urinary retention, decrease in hospital stay. Therefore, it seems to be suitable for outpatient anesthesia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Scalp Block With Bupivacaine Versus Levobupivacaine
NCT02497040
Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration
NCT01675895
Peritonsillar Infiltration With Levobupivacaine for Posttonsillectomy Pain
NCT02322346
Comparison of the Effect of Lidocaine Infusion Applied at Different Doses During Lumbar Spinal Surgery on Hemodynamics and Postoperative Pain
NCT05936190
Bupivacaine Levels After ESPB
NCT04239053
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
levobupivacaine I
group that was administered levobupivacaine plus 60mg dextrose
levobupivacaine
levobupivacaine plus 60 mg dextrose
levobupivacaine II
group that was administered levobupivacaine plus 80 mg dextrose
levobupivacaine
levobupivacaine plus 80 mg dextrose
levobupivacaine III
group that was administered levobupivacaine plus 100 mg dextrose
levobupivacaine
levobupivacaine plus 100 mg dextrose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
levobupivacaine
levobupivacaine plus 60 mg dextrose
levobupivacaine
levobupivacaine plus 80 mg dextrose
levobupivacaine
levobupivacaine plus 100 mg dextrose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American society of anesthesia (ASA) I,II physical status
* Scheduled for lower extremity surgery
Exclusion Criteria
* American society of anesthesia (ASA)III, IV physical status
* Hypersensitivity to local anesthetics
* Emergency surgery
* Chronic pain treatment
* Peripheral neuropathy
* Severe systemic disease
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ordu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
özgür yağan
Özgür Yağan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anestesia and Reanimation Dept.; Ordu University Education and Research Hospital
Ordu, Ordu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
odu52
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.